Cargando…

Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba

Naegleria fowleri is a pathogenic, thermophilic, free-living amoeba which causes primary amebic meningoencephalitis (PAM). Penetrating the olfactory mucosa, the brain-eating amoeba travels along the olfactory nerves, burrowing through the cribriform plate to its destination: the brain’s frontal lobe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tillery, Logan, Barrett, Kayleigh, Goldstein, Jenna, Lassner, Jared W., Osterhout, Bram, Tran, Nathan L., Xu, Lily, Young, Ryan M., Craig, Justin, Chun, Ian, Dranow, David M., Abendroth, Jan, Delker, Silvia L., Davies, Douglas R., Mayclin, Stephen J., Calhoun, Brandy, Bolejack, Madison J., Staker, Bart, Subramanian, Sandhya, Phan, Isabelle, Lorimer, Donald D., Myler, Peter J., Edwards, Thomas E., Kyle, Dennis E., Rice, Christopher A., Morris, James C., Leahy, James W., Manetsch, Roman, Barrett, Lynn K., Smith, Craig L., Van Voorhis, Wesley C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990177/
https://www.ncbi.nlm.nih.gov/pubmed/33760815
http://dx.doi.org/10.1371/journal.pone.0241738
_version_ 1783669027290218496
author Tillery, Logan
Barrett, Kayleigh
Goldstein, Jenna
Lassner, Jared W.
Osterhout, Bram
Tran, Nathan L.
Xu, Lily
Young, Ryan M.
Craig, Justin
Chun, Ian
Dranow, David M.
Abendroth, Jan
Delker, Silvia L.
Davies, Douglas R.
Mayclin, Stephen J.
Calhoun, Brandy
Bolejack, Madison J.
Staker, Bart
Subramanian, Sandhya
Phan, Isabelle
Lorimer, Donald D.
Myler, Peter J.
Edwards, Thomas E.
Kyle, Dennis E.
Rice, Christopher A.
Morris, James C.
Leahy, James W.
Manetsch, Roman
Barrett, Lynn K.
Smith, Craig L.
Van Voorhis, Wesley C.
author_facet Tillery, Logan
Barrett, Kayleigh
Goldstein, Jenna
Lassner, Jared W.
Osterhout, Bram
Tran, Nathan L.
Xu, Lily
Young, Ryan M.
Craig, Justin
Chun, Ian
Dranow, David M.
Abendroth, Jan
Delker, Silvia L.
Davies, Douglas R.
Mayclin, Stephen J.
Calhoun, Brandy
Bolejack, Madison J.
Staker, Bart
Subramanian, Sandhya
Phan, Isabelle
Lorimer, Donald D.
Myler, Peter J.
Edwards, Thomas E.
Kyle, Dennis E.
Rice, Christopher A.
Morris, James C.
Leahy, James W.
Manetsch, Roman
Barrett, Lynn K.
Smith, Craig L.
Van Voorhis, Wesley C.
author_sort Tillery, Logan
collection PubMed
description Naegleria fowleri is a pathogenic, thermophilic, free-living amoeba which causes primary amebic meningoencephalitis (PAM). Penetrating the olfactory mucosa, the brain-eating amoeba travels along the olfactory nerves, burrowing through the cribriform plate to its destination: the brain’s frontal lobes. The amoeba thrives in warm, freshwater environments, with peak infection rates in the summer months and has a mortality rate of approximately 97%. A major contributor to the pathogen’s high mortality is the lack of sensitivity of N. fowleri to current drug therapies, even in the face of combination-drug therapy. To enable rational drug discovery and design efforts we have pursued protein production and crystallography-based structure determination efforts for likely drug targets from N. fowleri. The genes were selected if they had homology to drug targets listed in Drug Bank or were nominated by primary investigators engaged in N. fowleri research. In 2017, 178 N. fowleri protein targets were queued to the Seattle Structural Genomics Center of Infectious Disease (SSGCID) pipeline, and to date 89 soluble recombinant proteins and 19 unique target structures have been produced. Many of the new protein structures are potential drug targets and contain structural differences compared to their human homologs, which could allow for the development of pathogen-specific inhibitors. Five of the structures were analyzed in more detail, and four of five show promise that selective inhibitors of the active site could be found. The 19 solved crystal structures build a foundation for future work in combating this devastating disease by encouraging further investigation to stimulate drug discovery for this neglected pathogen.
format Online
Article
Text
id pubmed-7990177
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-79901772021-04-05 Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba Tillery, Logan Barrett, Kayleigh Goldstein, Jenna Lassner, Jared W. Osterhout, Bram Tran, Nathan L. Xu, Lily Young, Ryan M. Craig, Justin Chun, Ian Dranow, David M. Abendroth, Jan Delker, Silvia L. Davies, Douglas R. Mayclin, Stephen J. Calhoun, Brandy Bolejack, Madison J. Staker, Bart Subramanian, Sandhya Phan, Isabelle Lorimer, Donald D. Myler, Peter J. Edwards, Thomas E. Kyle, Dennis E. Rice, Christopher A. Morris, James C. Leahy, James W. Manetsch, Roman Barrett, Lynn K. Smith, Craig L. Van Voorhis, Wesley C. PLoS One Research Article Naegleria fowleri is a pathogenic, thermophilic, free-living amoeba which causes primary amebic meningoencephalitis (PAM). Penetrating the olfactory mucosa, the brain-eating amoeba travels along the olfactory nerves, burrowing through the cribriform plate to its destination: the brain’s frontal lobes. The amoeba thrives in warm, freshwater environments, with peak infection rates in the summer months and has a mortality rate of approximately 97%. A major contributor to the pathogen’s high mortality is the lack of sensitivity of N. fowleri to current drug therapies, even in the face of combination-drug therapy. To enable rational drug discovery and design efforts we have pursued protein production and crystallography-based structure determination efforts for likely drug targets from N. fowleri. The genes were selected if they had homology to drug targets listed in Drug Bank or were nominated by primary investigators engaged in N. fowleri research. In 2017, 178 N. fowleri protein targets were queued to the Seattle Structural Genomics Center of Infectious Disease (SSGCID) pipeline, and to date 89 soluble recombinant proteins and 19 unique target structures have been produced. Many of the new protein structures are potential drug targets and contain structural differences compared to their human homologs, which could allow for the development of pathogen-specific inhibitors. Five of the structures were analyzed in more detail, and four of five show promise that selective inhibitors of the active site could be found. The 19 solved crystal structures build a foundation for future work in combating this devastating disease by encouraging further investigation to stimulate drug discovery for this neglected pathogen. Public Library of Science 2021-03-24 /pmc/articles/PMC7990177/ /pubmed/33760815 http://dx.doi.org/10.1371/journal.pone.0241738 Text en © 2021 Tillery et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Tillery, Logan
Barrett, Kayleigh
Goldstein, Jenna
Lassner, Jared W.
Osterhout, Bram
Tran, Nathan L.
Xu, Lily
Young, Ryan M.
Craig, Justin
Chun, Ian
Dranow, David M.
Abendroth, Jan
Delker, Silvia L.
Davies, Douglas R.
Mayclin, Stephen J.
Calhoun, Brandy
Bolejack, Madison J.
Staker, Bart
Subramanian, Sandhya
Phan, Isabelle
Lorimer, Donald D.
Myler, Peter J.
Edwards, Thomas E.
Kyle, Dennis E.
Rice, Christopher A.
Morris, James C.
Leahy, James W.
Manetsch, Roman
Barrett, Lynn K.
Smith, Craig L.
Van Voorhis, Wesley C.
Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba
title Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba
title_full Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba
title_fullStr Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba
title_full_unstemmed Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba
title_short Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba
title_sort naegleria fowleri: protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990177/
https://www.ncbi.nlm.nih.gov/pubmed/33760815
http://dx.doi.org/10.1371/journal.pone.0241738
work_keys_str_mv AT tillerylogan naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT barrettkayleigh naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT goldsteinjenna naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT lassnerjaredw naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT osterhoutbram naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT trannathanl naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT xulily naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT youngryanm naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT craigjustin naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT chunian naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT dranowdavidm naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT abendrothjan naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT delkersilvial naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT daviesdouglasr naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT mayclinstephenj naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT calhounbrandy naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT bolejackmadisonj naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT stakerbart naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT subramaniansandhya naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT phanisabelle naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT lorimerdonaldd naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT mylerpeterj naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT edwardsthomase naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT kyledennise naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT ricechristophera naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT morrisjamesc naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT leahyjamesw naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT manetschroman naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT barrettlynnk naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT smithcraigl naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba
AT vanvoorhiswesleyc naegleriafowleriproteinstructurestofacilitatedrugdiscoveryforthedeadlypathogenicfreelivingamoeba